Dr Reddy’s seeks emergency use approval for Sputnik V vaccine in India

Dr Reddy’s seeks emergency use approval for Sputnik V vaccine in India

Dr Reddy’s Laboratories has sought emergency use authorisation for Russia’s Sputnik V COVID-19 vaccine in India. The vaccine is currently undergoing Phase 3 clinical trial in India, which is expected to be complete by February 21, Dr Reddy’s said. Sputnik V showed 91.6% efficacy in the interim analysis of the Phase 3 study, which included 19,866 Russian volunteers, it added.

News source : Reuters

Leave a Reply

Your email address will not be published.